10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021

被引:372
作者
不详
机构
关键词
CORONARY-ARTERY-DISEASE; PRESSURE-LOWERING TREATMENT; AMERICAN-HEART-ASSOCIATION; TYPE-2; DIABETES-MELLITUS; STATIN-INTOLERANT PATIENTS; BASE-LINE CHARACTERISTICS; 14; RANDOMIZED-TRIALS; LOW-DOSE ASPIRIN; LONG-TERM RISK; BLOOD-PRESSURE;
D O I
10.2337/dc21-S010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S125 / S150
页数:26
相关论文
共 196 条
[1]  
Abalos E, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002252.pub2, 10.1002/14651858.CD002252.pub3]
[2]   Blood pressure targets for hypertension in people with diabetes mellitus [J].
Agustin Arguedas, Jose ;
Leiva, Viriam ;
Wright, James M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10)
[3]  
Al-Balas M, 2009, CAN FAM PHYSICIAN, V55, P44
[4]   Achievement of Goals in U.S. Diabetes Care, 1999-2010 [J].
Ali, Mohammed K. ;
Bullard, Kai McKeever ;
Saaddine, Jinan B. ;
Cowie, Catherine C. ;
Imperatore, Giuseppina ;
Gregg, Edward W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17) :1613-1624
[5]   Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy [J].
Anand, DV ;
Lim, E ;
Hopkins, D ;
Corder, R ;
Shaw, LJ ;
Sharp, P ;
Lipkin, D ;
Lahiri, A .
EUROPEAN HEART JOURNAL, 2006, 27 (06) :713-721
[6]  
[Anonymous], 2008, Guidance for industry: diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
[7]  
[Anonymous], 2016, FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme
[8]   Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus A Scientific Statement From the American Heart Association [J].
Arnold, Suzanne, V ;
Bhatt, Deepak L. ;
Barsness, Gregory W. ;
Beatty, Alexis L. ;
Deedwania, Prakash C. ;
Inzucchi, Silvio E. ;
Kosiborod, Mikhail ;
Leiter, Lawrence A. ;
Lipska, Kasia J. ;
Newman, Jonathan D. ;
Welty, Francine K. .
CIRCULATION, 2020, 141 (19) :E779-E806
[9]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[10]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278